Melatonin Vitabalans (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This interaction signals nighttime to the body, reduces neuronal activity, and promotes the physiological processes that lead to sleep, thereby aligning the circadian rhythm with the external light‑dark cycle.

The appropriate dose of Melatonin Vitabalans is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for melatonin use in pregnancy and breastfeeding are limited. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare provider before using Melatonin Vitabalans.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Unlike many prescription hypnotics, melatonin is a hormone‑based agent that works by normalizing the circadian rhythm rather than directly depressing the central nervous system. This mechanism often results in fewer next‑day sedation effects, but efficacy may vary depending on the specific sleep disorder being treated.

Melatonin Vitabalans should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Melatonin Vitabalans is taken orally, typically with a glass of water. It is usually administered shortly before the intended bedtime, but the exact timing and method should follow the prescribing clinician’s directions.

Serious risks, though rare, include allergic reactions such as rash or swelling, severe dizziness, mood changes like depression or hallucinations, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to melatonin, those taking certain interacting medications (e.g., strong CYP1A2 inhibitors), or patients with uncontrolled epilepsy, severe depression, or significant liver disease should avoid using Melatonin Vitabalans unless advised otherwise by a healthcare professional.